Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1368981 | Bioorganic & Medicinal Chemistry Letters | 2015 | 4 Pages |
Abstract
Inspired by naturally occurring host defense peptides, cationic amphipathic peptoids provide a promising scaffold for anti-cancer therapeutics. Herein, we report a library of peptide–peptoid hybrid prodrugs that can be selectively activated by prostate cancer cells. We have identified several compounds demonstrating potent anti-cancer activity with good to moderate selectivity. We believe that these prodrugs can provide a useful design principle for next generation peptide–peptoid hybrid prodrugs.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jiyoun Lee, Wei Huang, James M. Broering, Annelise E. Barron, Jiwon Seo,